Lv1
40 积分 2024-10-06 加入
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
3天前
已完结
Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
18天前
已完结
SGLT2 Inhibitors May Predispose to Ketoacidosis
25天前
已完结
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
1个月前
已完结
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
1个月前
已完结
Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
3个月前
已完结
Metformin hydrochloride microencapsulation by complex coacervation: Study of size distribution and encapsulation yield using response surface methodology
3个月前
已完结
Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS
4个月前
已完结
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
5个月前
已完结
Pediatric Drug-Induced Anaphylaxis Reports in the FDA Adverse Event Reporting System (FAERS)
6个月前
已完结
皖公网安备34019202002308
